$MYGN $TMO $ILMN: IBD Stock Of The Day: Genetics Firm Breaks Out On Cancer Testing Trends

Date: Wednesday, July 11th, 2018

Stock(s) mentioned: , ,

Source: Investor’s Business Daily (http://www.investors.com)

Summary:

Myriad Genetics is the IBD Stock Of The Day after it broke out on an analyst upgrade noting trends in cancer genetics testing are stabilizing.

The post IBD Stock Of The Day: Genetics Firm Breaks Out On Cancer Testing Trends appeared first on Investor’s Business Daily.

Full article address: https://www.investors.com/news/technology/myriad-stock-improved-cancer-tests/

Latest News:

$FCAU $RACE $CNHI: Fiat Chrysler Names Jeep Chief Manley To Replace CEO Marchionne

$BA $EADSY $FDX $LMT: Boeing 797 Doubts And 4 Other Things You May Have Missed At Farnborough

$LOXO $BPMC $DCPH $NVS $PFE: How These Biotech Companies Hope To Fight Cancer With Precision Medicine

$GSK $NVS: GlaxoSmithKline Reportedly Mulling A Spinoff Of Consumer Unit

$ISRG $JNJ $MDT $MZOR $ZBH: Will A ‘Moat’ Continue Protecting This Big Cap 20 From Rivals?

$SPOT $P $GOOGL $AMZN $AAPL: Spotify Stock Gets Price-Target Hikes Ahead Of Earnings Report

$FB: Facebook Stock Hits Record High As Advertising Prospects Hailed

$MRK $PFE: Dow’s Merck Falls In Line Behind Pfizer On Drug-Pricing Plans

$NFLX: Netflix Subscribers Upgrading To Premium Service Tier

$BA $EADSY $FDX $LMT: 5 Things That Flew Below The Radar At The Farnborough Airshow

$GE $HON $UTX $BHGE: GE Stock Dives On Cash Target; Honeywell Earnings Top

Related News:

$TMO: Thermo Fisher Scientific Highlights Digital Science Innovations at …